163 related articles for article (PubMed ID: 24981246)
1. Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival.
Zhou J; Bi H; Zhan P; Chang C; Xu C; Huang X; Yu L; Yao X; Yan J
Tumour Biol; 2014 Oct; 35(10):9777-85. PubMed ID: 24981246
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
4. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.
Xie C; Jiang G; Fan C; Zhang X; Zhang Y; Miao Y; Lin X; Wu J; Wang L; Liu Y; Yu J; Yang L; Zhang D; Xu K; Wang E
Tumour Biol; 2014 Sep; 35(9):8903-11. PubMed ID: 24894675
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
[TBL] [Abstract][Full Text] [Related]
6. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.
Hu M; Ye L; Ruge F; Zhi X; Zhang L; Jiang WG
BMC Cancer; 2012 Dec; 12():588. PubMed ID: 23228205
[TBL] [Abstract][Full Text] [Related]
8. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
[TBL] [Abstract][Full Text] [Related]
10. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
11. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
12. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
13. Significant role of Psf3 expression in non-small-cell lung cancer.
Tane S; Sakai Y; Hokka D; Okuma H; Ogawa H; Tanaka Y; Uchino K; Nishio W; Yoshimura M; Maniwa Y
Cancer Sci; 2015 Nov; 106(11):1625-34. PubMed ID: 26291987
[TBL] [Abstract][Full Text] [Related]
14. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
16. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
19. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.
Yu Y; Wang Z; Zhang MY; Liu XY; Zhang H
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):166-9. PubMed ID: 20935042
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
